ペンシルベニアにおける脂肪肝の臨床試験
ペンシルベニア内の拠点で、脂肪肝に関する5件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
- Geisinger Medical Center, Danville
- Penn State Health Milton S. Hershey Medical Center, Hershey
- University of Pennsylvania - Perelman Center for Advanced Medicine, Philadelphia
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/25更新 · NCT05519475A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- US Digestive Health - Flourtown, Flourtown
- Penn Medicine: University of Pennsylvania Health System, Philadelphia
- US Digestive Health - Wyomissing, Wyomissing
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07165028A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
- Akero Clinical Study Site, Hershey
- Akero Clinical Study Site, Philadelphia
- Akero Clinical Study Site, Philadelphia
- 他1件
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/09/21更新 · NCT06528314A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Philadelphia
- 89bio Clinical Study Site, Pittsburgh
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/09/03更新 · NCT06419374A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
- GSK Investigational Site, Philadelphia
被験者募集中第2相
18歳〜70歳 · 全性別 · 2026/08/03更新 · NCT06613698ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。